Rand Paul's Biosimilar Drug Bill Could Cut Costs, Speed Patient Access
Source: reason.com ·
Section: politics ·
Bias: Center-Right
· Published: Fri, 31 Jul 2026 17:20:15 GMT
The Expedited Access to Biosimilars Act enables FDA approval of pharmaceutically equivalent biologic medications.
Read the full article at reason.com →
The same story across the political spectrum (1 sources)
← Back to FlashTopics.com